(19)
(11) EP 4 823 629 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24904726.7

(22) Date of filing: 10.12.2024
(51) International Patent Classification (IPC): 
A61K 48/00(2006.01)
A61P 27/16(2006.01)
A61B 5/12(2006.01)
C07K 14/47(2006.01)
A61F 11/20(2022.01)
(52) Cooperative Patent Classification (CPC):
A61B 5/12; C07K 14/47; A61P 27/16; C12N 15/86; C12N 2800/40; C12N 2750/14143; C12N 2830/42; A61K 48/005; A61K 48/0066; A61F 11/00
(86) International application number:
PCT/US2024/059365
(87) International publication number:
WO 2025/128559 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 11.12.2023 US 202363608803 P
02.02.2024 US 202463549424 P

(71) Applicant: Akouos, Inc.
Boston, MA 02210 (US)

(72) Inventors:
  • WELLMAN, Jennifer
    Boston, MA 02210 (US)
  • SIMONS, Emmanuel John
    Boston, MA 02210 (US)
  • VALERO, Michelle
    Boston, MA 02210 (US)
  • SEWELL, William
    Boston, MA 02210 (US)
  • HICKOX, Ann
    Boston, MA 02210 (US)
  • NG, Robert
    Boston, MA 02210 (US)

(74) Representative: Eli Lilly and Company Limited 
8 Arlington Square West Downshire Way
Bracknell, Berkshire RG12 1PU
Bracknell, Berkshire RG12 1PU (GB)

   


(54) COMPOSITIONS AND METHODS FOR TREATING HEARING LOSS IN A HUMAN SUBJECT HAVING A DEFECTIVE OTOFERLIN GENE